Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Jane Macaskill

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The Breast Journal|July 5, 2012
Endocrine therapy in DCIS: how do we proceed?J Michael Dixon, E Jane Macaskill
The Breast Journal|April 28, 2007
Neoadjuvant use of endocrine therapy in breast cancerE Jane Macaskill, J Michael Dixon
The Oncologist|November 18, 2006
Neoadjuvant use of hormonal therapy in elderly patients with early or locally advanced hormone receptor-positive breast cancerE Jane Macaskill, Lorna Renshaw, J Michael Dixon
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 6, 2020
The prognostic impact of mode of detection of axillary metastases for women with invasive breast cancer: A retrospective observational studyKirsty McNeil, E Jane Macaskill, Colin Purdie, et al.
The British Journal of Radiology|September 30, 2021
A retrospective review of MRI features associated with metastasis-free survival in women with breast cancer: focusing on skin thickening and skin enhancementValentine Mberu, Jennifer McFarlane, E Jane Macaskill, et al.
Trials|June 6, 2021
Letter on "Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK - experience from the ActWELL trial"Hanne Bruhn, Annie S Anderson, Amy Hickman, et al.
Breast (Edinburgh, Scotland)|December 10, 2021
A pre-operative prognostic model predicting all cause and cause specific mortality for women presenting with invasive breast cancerHuan Wang, Peter Donnan, E Jane Macaskill, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 19, 2005
Surgical issues surrounding use of aromatase inhibitorsJ Michael Dixon, Lorna Renshaw, Juliette Murray, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|April 20, 2021
Age and cancer treatment factors influence patient-reported outcomes following therapeutic mammoplasty and contralateral symmetrisation for the treatment of breast cancerWen Ling Choong, Rosie E Andrew, Fiona J Hogg, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|November 22, 2022
Indocyanine Green Is a Safe and Effective Alternative to Radioisotope in Breast Cancer Sentinel Lymph Node Biopsy regardless of Patient Body Mass IndexSamantha Ng, Vassilis Pitsinis, Emad H Elseedawy, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The Breast Journal|July 5, 2012
Endocrine therapy in DCIS: how do we proceed?J Michael Dixon, E Jane Macaskill
The Breast Journal|April 28, 2007
Neoadjuvant use of endocrine therapy in breast cancerE Jane Macaskill, J Michael Dixon
The Oncologist|November 18, 2006
Neoadjuvant use of hormonal therapy in elderly patients with early or locally advanced hormone receptor-positive breast cancerE Jane Macaskill, Lorna Renshaw, J Michael Dixon
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 6, 2020
The prognostic impact of mode of detection of axillary metastases for women with invasive breast cancer: A retrospective observational studyKirsty McNeil, E Jane Macaskill, Colin Purdie, et al.
The British Journal of Radiology|September 30, 2021
A retrospective review of MRI features associated with metastasis-free survival in women with breast cancer: focusing on skin thickening and skin enhancementValentine Mberu, Jennifer McFarlane, E Jane Macaskill, et al.
Trials|June 6, 2021
Letter on "Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK - experience from the ActWELL trial"Hanne Bruhn, Annie S Anderson, Amy Hickman, et al.
Breast (Edinburgh, Scotland)|December 10, 2021
A pre-operative prognostic model predicting all cause and cause specific mortality for women presenting with invasive breast cancerHuan Wang, Peter Donnan, E Jane Macaskill, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 19, 2005
Surgical issues surrounding use of aromatase inhibitorsJ Michael Dixon, Lorna Renshaw, Juliette Murray, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|April 20, 2021
Age and cancer treatment factors influence patient-reported outcomes following therapeutic mammoplasty and contralateral symmetrisation for the treatment of breast cancerWen Ling Choong, Rosie E Andrew, Fiona J Hogg, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|November 22, 2022
Indocyanine Green Is a Safe and Effective Alternative to Radioisotope in Breast Cancer Sentinel Lymph Node Biopsy regardless of Patient Body Mass IndexSamantha Ng, Vassilis Pitsinis, Emad H Elseedawy, et al.
Pageof 3